Hemophilia Alliance Meeting at THSNA
The Hemophilia Alliance will be holding a Pre-Conference session at HTRS/THSNA on Wednesday April 22nd, 2020. The meeting begins at 1 pm. It will be led by Joseph Pugliese, President and CEO of the Hemophilia Alliance. The topic of the session is “Sustainability of the HTC Pharmacy (340B) with Emerging Therapies”. This will be an interactive session where we discuss financial models for emerging therapies. The current and pending changes make maintaining and growing your current business and expanding your footprint critical for sustaining the comprehensive care mode. The Hemophilia Alliance continues to work with Insurance Companies, Brokers and Consultants to keep HTCs in network and continue to give them access to provide pharmacy services in dispensing factor products to their patients.
Lunch will be served at the meeting.